Sarcopenia screening and clinical outcomes in surgical patients: A longitudinal study
Nutrition in Clinical Practice · 2025
DOI: 10.1002/ncp.11243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrition in Clinical Practice, 2025. Verfasst von Micheli da Silva Tarnowski und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Nutrition Sciences, Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Sarcopenia, Postoperative Complications, Elective Surgical Procedures, Mass Screening. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Micheli da Silva Tarnowski received a scholarship as a Master's student from the Federal University of Health Science of Porto Alegre. Flávia Moraes Silva rece….
Abstract (Originalsprache)
Background
The SARC‐CalF was developed as a screening tool for sarcopenia, but little is still known about its validity in surgical patients. Thus, this study aimed to assess the prognostic value of SARC‐CalF in predicting clinical outcomes in patients admitted for any elective surgery in a hospital.
Methods
Cohort study with prospective data collection of surgical patients ≥18 years of age screened for sarcopenia within 48 h of admission using the SARC‐CalF (score ≥11 points classified patients at suggestive signs of sarcopenia). A standard questionnaire for sociodemographic and clinical data was filled and anthropometric data were measured. Clinical outcomes of interest comprised postoperative complications, length of postoperative hospital stay (LPHS), length of hospital stay (LOS), and in‐hospital death.
Results
Among the 303 patients admitted for elective surgery across various specialties (58.2 ± 14.6 years; 53.8% men) included, 21.5% presented suggestive signs of sarcopenia (SARC‐CalF ≥11). LOS (16.0 [10.0–29.0] vs 13.5 [8.0–22.0] days; P < 0.05) and LPHS (6.0 [3.0–14.5] vs 5.0 [1.0–8.2] days; P < 0.05) were longer in patients with SARC‐CalF ≥11 compared with those without this condition. The frequency of severe postoperative complications (23.1% vs 8.8%; P < 0.05) and the incidence of death (12.3% vs 2.9%; P < 0.05) were higher in patients with SARC‐CalF ≥11. However, in the multivariate analyses, no association between SARC‐CalF ≥11 and clinical outcomes was found.
Conclusion
Signs of sarcopenia (SARC‐CalF ≥11) were present in >20% of patients who were hospitalized for any elective surgery, but it was not an independent predictor of extended hospital stay, complications, and death.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate Program in Nutrition Sciences, Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil.
- Federal University of Health Science of Porto Alegre, Rio Grande do Sul, Brazil.
- Graduate Program in Nutrition Sciences and Nutrition Department, Federal University of Health Sciences of Porto Alegre, Porto Alegre, RS, Brazil.
Förderung
- Micheli da Silva Tarnowski received a scholarship as a Master's student from the Federal University of Health Science of Porto Alegre. Flávia Moraes Silva rece…
Zitieren
APA
Tarnowski, M. D. S., Burgel, C. F., Dariva, A. A., Marques, I. C., Alves, L. P., Beretta, M. V., Silva, F. M., & Gottschall, C. B. A. (2025). Sarcopenia screening and clinical outcomes in surgical patients: A longitudinal study. Nutrition in Clinical Practice. https://doi.org/10.1002/ncp.11243
Vancouver
Tarnowski MDS, Burgel CF, Dariva AA, Marques IC, Alves LP, Beretta MV, et al. Sarcopenia screening and clinical outcomes in surgical patients: A longitudinal study. Nutrition in Clinical Practice. 2025. doi:10.1002/ncp.11243
BibTeX
@article{Tarnowski2025,
author = {Tarnowski, Micheli da Silva and Burgel, Camila Ferri and Dariva, Andressa Amaral and Marques, Isabela Canquerini and Alves, Lana Porto and Beretta, Mileni V and Silva, Flávia Moraes and Gottschall, Catarina B Andreatta},
title = {Sarcopenia screening and clinical outcomes in surgical patients: A longitudinal study},
journal = {Nutrition in Clinical Practice},
year = {2025},
doi = {10.1002/ncp.11243}
}
EUVIMED